AZN : Summary for Astrazeneca PLC Common Stock - Yahoo Finance

U.S. Markets closed

AstraZeneca PLC (AZN)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
27.16+0.89 (+3.39%)
At close: 4:00 PM EST
People also watch:
GSKNVSSNYLLYBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close26.27
Open26.97
Bid27.23 x 100
Ask27.38 x 1000
Day's Range26.70 - 27.42
52 Week Range25.55 - 35.04
Volume8,677,307
Avg. Volume6,462,623
Market Cap68.01B
Beta0.56
PE Ratio (TTM)27.87
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.90 (3.46%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • How AstraZeneca plc (ADR) (AZN) Stacks Up Against Its Peers
    Insider Monkey6 hours ago

    How AstraZeneca plc (ADR) (AZN) Stacks Up Against Its Peers

    At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices. Out of thousands of stocks that hedge funds invest in, small-caps […]

  • Broadcom, Finisar Price Targets Hiked; AstraZeneca A Top Pick
    Investor's Business Daily11 hours ago

    Broadcom, Finisar Price Targets Hiked; AstraZeneca A Top Pick

    Broadcom and Finisar got price-target hikes after beating earnings estimates late Thursday, while Astrazeneca got an upgrade.

  • Reuters15 hours ago

    AstraZeneca's immunotherapy enters U.S. approval process

    AstraZeneca's immunotherapy drug durvalumab, the British drugmaker's most important pipeline medicine, has been accepted for review by U.S. regulators against bladder cancer, potentially its first use. ...